Flu Vaccine's hidden power: boosting nose immunity?
NCT ID NCT06824779
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how the flu vaccine changes immune cells in the nose and blood. Researchers will collect samples from 30 healthy adults before and after they get the flu shot. The goal is to understand if the vaccine creates 'resident memory' immune cells in the nose, which could block the flu virus at its entry point.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Flu vaccine
- What this could lead to
- If successful, this study could help design better flu vaccines that boost immunity right where the virus enters—the nose.
- What could go wrong
- This is a small, early-stage observational study with only 30 participants. It measures immune markers, not actual protection, so results may not lead to immediate changes in vaccination.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FLU VACCINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Saint-Etienne
Saint-Etienne, 42055, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new AI denoiser make Low-Dose CT scans crystal clear?
- Phone vs. desktop: does screen size skew stress surveys?
- Is your home blood pressure cuff accurate? new study aims to find out
- Brain scans and virtual reality aim to decode chronic breathlessness
- Spinal injury study seeks to unlock vaccine secrets
- Bern police officers tested for COVID-19 immunity over one year